Accuracy of dynamic navigation compared with static navigation for guided endodontic microsurgery: A randomised controlled trial.

J DentMay 15, 2026 (epub)
Clinical ResearchGeneral SurgeryOphthalmology

Chen Chen, Rui Zhang, Li Qin et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial compared the accuracy of static navigation (SN) and dynamic navigation (DN) in guided endodontic microsurgery among 18 patients. The study found that the SN group had significantly greater end-point deviation (ED) compared to the DN group (p = 0.02), indicating that DN may offer superior accuracy in complex surgical cases.

Key findings

  • The SN group showed significantly greater end-point deviation (ED) compared to the DN group (p = 0.02).
  • No significant differences were found between groups for start-point deviation, angular deviation, root-end resection length deviation, or root-end resection angle deviation (p > 0.05).
  • Both navigation methods achieved clinically acceptable accuracy for endodontic microsurgery.

Why it matters

Understanding the differences in accuracy between navigation techniques can help clinicians choose the most effective approach for guided endodontic microsurgery, particularly in complex cases where precision is critical.

Source

PubMed · PMID 42142615

Published in J Dent. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in General Surgery

Clinical ResearchHematology

Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.

This multicenter, phase 3 randomized trial compared frontline ponatinib plus blinatumomab with imatinib plus chemotherapy in adults with Philadelphia-positive acute lymphoblastic leukemia.

N Engl J MedOct 15, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary
Clinical ResearchRheumatology

Ianalumab for the Treatment of Patients with Sjögren's Disease.

Two 52-week, double-blind, randomized, placebo-controlled phase III trials evaluated monthly or less frequent ianalumab in patients with active Sjögren's disease.

N Engl J MedOct 22, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text
Create my personalized digestSee plans

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.